Latest News About - Klebsiella

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Monday, December 10, 2018

11:00:00 PM CET

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Jose Bengoechea explains: “As the antibiotics we currently use are inefficient at targeting bacteria that live inside our cells, this finding has important clinical implications on how we treat Klebsiella infections,” External link

ec-europa Thursday, December 6, 2018 12:15:00 PM CET

Jose Bengoechea says: “What we see is a close relationship between Klebsiella’s antibiotic resistance and its virulence, or ability to infect a resistant host,” “These findings emphasise the importance of evaluating both antibiotic resistance and virulence in order to better monitor a patient’s outcome” External link

ec-europa Thursday, December 6, 2018 12:15:00 PM CET

Jose Bengoechea adds: “I believe this host-directed therapeutic approach will limit the pathogen’s ability to develop resistance against new treatments,” “We already obtained very promising results in animal models in which, without the need for antibiotics, we were able to reduce the infection by more than 80 %” External link

ec-europa Thursday, December 6, 2018 12:15:00 PM CET

Jose Bengoechea explains: “Interferons activate macrophages and natural killer cells to control Klebsiella pneumonia,” “What this finding means is that interferons could be considered for new therapeutics developments” External link

ec-europa Thursday, December 6, 2018 12:15:00 PM CET

Jose Bengoechea concludes: “Although we are still at the very early stages, these potential new treatments will have a major health impact, especially considering the increasing number of Klebsiella infections worldwide and the limited treatment options available,” External link

ec-europa Thursday, December 6, 2018 12:15:00 PM CET

David Coil said: "These kinds of stories are irritating," External link

sciencealert Friday, November 30, 2018 1:16:00 AM CET

Paul Matewele said: "If people know about it, they can do something. … They can probably take something like an anti-bacterial cleanser," External link

sciencealert Friday, November 30, 2018 1:16:00 AM CET

Paul Matewele spiega: "È contagioso. Se ci si tocca il naso con le dita, poi lo trasferisce sul touchscreen, qualcun'altro lo prende e se ha un taglio aperto in cui entra, allora può essere pericoloso" External link

ilgiornale Thursday, November 29, 2018 11:40:00 AM CET

Jack Bloom said: "Year after year, we hear that the department is going to be turned around, but we still don’t have a clean audit report," External link

iol Tuesday, November 27, 2018 11:41:00 AM CET

Jack Bloom added: "I hope that occupational safety and hygiene risks are tackled effectively at our hospitals and clinics to avoid more disasters," External link

iol Tuesday, November 27, 2018 11:41:00 AM CET

Raed Arafat : ”Nu, n-am primit nicio cerere, deci 30 %, estimează colegii de la Iași, dacă este nevoie ne anunță” External link

stirileprotv Saturday, November 10, 2018 3:32:00 PM CET

Jordi Vila explica: “Tienen una elevada prevalencia en los hospitales, fundamentalmente Klebsiella pneumonia, resistentes a antibióticos de primera, segunda y tercera línea, por lo que la única opción terapéutica que les queda es colistina, que es bastante tóxica. Y aún así ya han aparecido bacterias resistentes a colistina. Necesitamos desesperadamente nuevos antibióticos” External link

lavanguardia Thursday, November 8, 2018 1:36:00 AM CET

Most associated names

Daily number of articles in this category

Trend data not available for this selection.